advertisement

---

Drug design, development and therapy 8

Showing records 1 to 8 | Display all abstracts in Drug design, development and therapy

70795 Impact of prostaglandin glaucoma drops on platelet-activating factor action: an in vitro study
Moschos MM
Drug design, development and therapy 2016; 10: 3977-3981

---

70468 α-Aminoadipic acid protects against retinal disruption through attenuating Müller cell gliosis in a rat model of acute ocular hypertension
Wang X; Su J
Drug design, development and therapy 2016; 10: 3449-3457

---

70795 Impact of prostaglandin glaucoma drops on platelet-activating factor action: an in vitro study
Nitoda E
Drug design, development and therapy 2016; 10: 3977-3981

---

70468 α-Aminoadipic acid protects against retinal disruption through attenuating Müller cell gliosis in a rat model of acute ocular hypertension
Ding J
Drug design, development and therapy 2016; 10: 3449-3457

---

70795 Impact of prostaglandin glaucoma drops on platelet-activating factor action: an in vitro study
Chatziralli IP; Panos GD
Drug design, development and therapy 2016; 10: 3977-3981

---

70468 α-Aminoadipic acid protects against retinal disruption through attenuating Müller cell gliosis in a rat model of acute ocular hypertension
Han S
Drug design, development and therapy 2016; 10: 3449-3457

---

70795 Impact of prostaglandin glaucoma drops on platelet-activating factor action: an in vitro study
Demopoulos CA
Drug design, development and therapy 2016; 10: 3977-3981

---

70468 α-Aminoadipic acid protects against retinal disruption through attenuating Müller cell gliosis in a rat model of acute ocular hypertension
Ma W; Luo H; Hughes G; Meng Z; Yin Y; Wang Y; Li J
Drug design, development and therapy 2016; 10: 3449-3457

---